#
Epigenetics Slideshow
Jan 31, 2020
Slideshow on epigenetics which was presented at the Wellstone Research Update 2020 by Peter Jones PhD.
#
Fulcrum Therapeutics Receives Orphan Drug Designation for Losmapimod in FSHD
Jan 30, 2020
Fulcrum Therapeutics announced that the FDA has granted Orphan Drug Designation to losmapimod, a selective p38α/β mitogen activated protein kinase (MAPK) inhibitor.
#
Progress Update: DUX4 mRNA silencing using CRISPR-Cas13
Jan 28, 2020
Rashnonajad provides the initial progress update showing efficiently reduced DUX4 mRNA and consequently DUX4 protein in FSHD cells.
#
Voice of the Patient Forum for Drug Development
Jan 9, 2020
The Friends of FSH Research is partnering with the FSHD Society on a landmark Voice of the Patient Forum for Drug Development.